EUVIMEDEUVIMED entdecken
Crossref

Representation in clinical trials sponsored by the United States Department of Veterans Affairs

Gabriela T Gomez iD, Brandon E Turner, Jecca R Steinberg, Miranda B Lam, Sherry M Wren

Journal of Public Health · 2025

DOI: 10.1093/pubmed/fdaf003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Public Health, 2025. Verfasst von Gabriela T Gomez und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Johns Hopkins School of Public Health, 615 N Wolfe St, Baltimore, MD 21205, USA. Hauptthemen laut MEDLINE: United States Department of Veterans Affairs, Clinical Trials as Topic, Patient Selection. Die Arbeit nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study was conducted to determine whether demographic representation among U.S. Department of Veterans Affairs (VA)-sponsored trials differs from trials without VA sponsorship, with reference to VA patient demographics.

Methods

U.S. clinical trials registered between 1 March 2000 and 1 February 2022 were stratified into VA and non-VA groups. Outcomes included the combined percentage of non-White participants in each trial and enrollment of each demographic subgroup. Trial strata were summarized using medians; Wilcoxon rank sum and one-sample signed rank tests were used to compare demographic representation between (i) VA and non-VA trials and (ii) VA trials and Veterans Health Administration (VHA) patient demographics, respectively.

Results

We identified 13,826 trials with available data, including 521 VA and 13,305 non-VA-sponsored trials. Median non-White enrollment was 68% greater in VA trials (P < .001) than in non-VA trials, driven by greater enrollment of Black participants (23.5% vs. 10.4%; P < .001). Black participant enrollment in VA trials exceeded representation among VHA beneficiaries (23.5% vs. 15.8%, P < .001).

Conclusions

This study highlights the increased Black representation in VA-sponsored clinical trials, which is greater than expected after accounting for VHA clinical population demographics. Partnership with the VA may represent a meaningful avenue for increasing Black representation in clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

United States Department of Veterans AffairsClinical Trials as TopicPatient SelectionHumansUnited StatesMaleFemaleMiddle AgedAgedVeterans

Stichwörter der Autor:innen

clinical trialdemographic representationraceveterans affairs

Autor:innen und Institutionen

  • Department of Epidemiology, Johns Hopkins School of Public Health, 615 N Wolfe St, Baltimore, MD 21205, USA.
  • Department of Radiation Oncology, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115, USA.
  • Department of Obstetrics and Gynecology, Northwestern School of Medicine, 250 E. Superior St. Chicago, IL 60611, USA.
  • Department of Surgery, Stanford University, 780 Welch Rd., Palo Alto, CA 94304, USA.
  • Palo Alto Veterans Health Care System, 3801 Miranda Ave, Palo Alto, CA 94304-1207, USA.

ORCID-Profile: Gabriela T Gomez

Zitieren

APA

Gomez, G. T., Turner, B. E., Steinberg, J. R., Lam, M. B., & Wren, S. M. (2025). Representation in clinical trials sponsored by the United States Department of Veterans Affairs. Journal of Public Health. https://doi.org/10.1093/pubmed/fdaf003

Vancouver

Gomez GT, Turner BE, Steinberg JR, Lam MB, Wren SM. Representation in clinical trials sponsored by the United States Department of Veterans Affairs. Journal of Public Health. 2025. doi:10.1093/pubmed/fdaf003

BibTeX
@article{Gomez2025,
  author = {Gomez, Gabriela T and Turner, Brandon E and Steinberg, Jecca R and Lam, Miranda B and Wren, Sherry M},
  title = {Representation in clinical trials sponsored by the United States Department of Veterans Affairs},
  journal = {Journal of Public Health},
  year = {2025},
  doi = {10.1093/pubmed/fdaf003}
}
Kostenlos starten →